Dermatology Nurses' Association Archive

Awards, Grants and Scholarships: Deadline Oct. 1, 2022

The Awards, Grants and Scholarships deadline for applications to be received and reviewed is October...

source:

Visit the DNA Education Activities Center for the latest DNP issue!

In this issue, we explore Trends in the Use of Systemic Therapies:...

source:

Banana Boat sunscreen recalled due to benzene

Edgewell Personal Care Co. has recalled three batches of its Banana Boat Hair & Scalp Sunscreen Spray SPF 30 because trace levels of benzene were found in some samples during an internal review. Though this sunscreen product is not meant to contain benzene, it may have come...

source: HealthDay News via Dermatology Advisor

COVID-19-related new-onset and exacerbated skin diseases

New-onset skin disease following COVID-19 infection can resolve spontaneously without medication, and the most common of such diseases is telogen effluvium, according to findings from a systematic review letter-to-the-editor published in The Journal of Dermatology. Neither...

source: Dermatology Advisor

Photoaggravated atopic dermatitis warrants more attention, testing

Photoaggravated atopic dermatitis, which affects people of varied ages and with different skin phototypes, has a significant impact on quality of life, according to a study. “This study’s findings suggest that improved knowledge...

source: Healio

Dermatologists share vitiligo breakthrough news with patients

For the first time, patients with vitiligo who have long lived with patches of skin that are without pigment can now have even skin tones on their faces and other bodily regions with a U.S. Food and Drug Administration-approved, easy-to-use...

source: Medscape

Asian psoriasis patients get less time with dermatologists, study suggests

Asian patients with psoriasis receive less face-to-face time with dermatologists, according to a cross-sectional study. Among over four million patient visits for psoriasis, mean duration of visit was 9.2 minutes for Asian patients...

source: Medpage Today

How has immunotherapy improved survival rates in patients with melanoma?

Though melanoma is not the most common form of skin cancer, it is considered to be the most serious and life-threatening. It is more likely to grow and metastasize, meaning that prompt treatment for advanced melanoma is crucial even...

source: Cancer Therapy Advisor

New Omicron COVID boosters coming soon: What to know now

New COVID-19 vaccine boosters, targeting new Omicron strains of the virus, are expected to roll out across the U.S. in September — a month ahead of schedule, the Biden administration announced this week. Moderna has signed a $1.74 billion federal contract to supply...

source: Medscape

Is the travel nurse pay boom really over?

As the travel nursing boom – fueled by demand during the pandemic and a nationwide nurse shortage – begins to show signs of fading, some experts believe the overall outlook for travel nurse wages will remain strong, even amid uncertainty in the healthcare labor...

source: Medpage Today

Novel tool measures general and COVID-19-specific sources of nurses' moral distress

The COVID‐19 pandemic created novel patient care circumstances that may have increased nurses' moral distress, including COVID‐19 transmission risk and end‐of‐life care without family present. Moral distress...

source: News-Medical

Poor treatment persistence reported for new acne patients

Persistence with treatments was poor in a cohort of individuals newly diagnosed with acne, according to study findings. Study author Steven R. Feldman, MD, PhD, professor of dermatology, pathology and social sciences and health policy at Wake Forest School of Medicine,...

source: Healio

Margin size associated with risk of local recurrence from melanoma in situ

Pathological excision margins of 4 mm or more may be a reliable indicator of the risk of recurrence of melanoma in situ following surgical excision of the cancer, according to findings from a new study that investigated the ability to predict local disease recurrence.

source: AJMC

Alopecia areata gets FDA-approved drug

Alopecia areata is a historically challenging-to-treat condition, with few effective therapy options. In June 2022, the FDA ended the wait for a specific treatment for this condition with its approval of the novel oral J Kinase inhibitor baricitinib as the first systemic...

source: Dermatology Times

Optimize acids, peels in acne scar treatment

Despite the widespread applications of lasers in rectifying acne scarring and the use of other modalities including microneedling with platelet-rich plasma, chemical peeling remains a mainstay of treating atrophic acne scars. "There is a tendency to throw the kitchen sink...

source: Dermatology Times

Subscribe to Dermatology Nurses' Association

*Email:
*First Name:
*Last Name:
*Company:
Title:
Street Address:
City:
State / Province:
Zip / Postal Code:
Country:

Are you a member of DNA?	Yes No


Privacy Policy

Browse Categories

Browse by Date

Nursing job outlook: The perfect storm brewing

Awards, Grants and Scholarships: Deadline Oct. 1, 2022

Visit the DNA Education Activities Center for the latest DNP issue!

Banana Boat sunscreen recalled due to benzene

COVID-19-related new-onset and exacerbated skin diseases

Photoaggravated atopic dermatitis warrants more attention, testing

Dermatologists share vitiligo breakthrough news with patients

Asian psoriasis patients get less time with dermatologists, study suggests

How has immunotherapy improved survival rates in patients with melanoma?

New Omicron COVID boosters coming soon: What to know now

Is the travel nurse pay boom really over?

Novel tool measures general and COVID-19-specific sources of nurses' moral distress

Poor treatment persistence reported for new acne patients

Margin size associated with risk of local recurrence from melanoma in situ

Alopecia areata gets FDA-approved drug

Optimize acids, peels in acne scar treatment

RECOMMENDED:

Subscribe to Dermatology Nurses' Association